Calcineurin inhibitors ± steroids vs placebo/no treatment/supportive treatment/steroids
End‐stage renal disease · primary membranous nephropathy in adults with nephrotic syndrome
It is very uncertain whether calcineurin inhibitors ± steroids changes end‐stage kidney disease at final compared with placebo/no treatment/supportive treatment/steroids (very low certainty).
1 finding from 1 review
- Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome 2021 · Cochrane Headline outcomes onlyRR 1.18 [0.54, 2.6]7 studies · 296 participantsVery low